In this study, the authors present optimization and efficacy testing of apolipoprotein-based lipid nanoparticles for delivering various nucleic acid therapeutics in vivo to immune cells and their progenitors in the bone marrow.
- Stijn R. J. Hofstraat
- Tom Anbergen
- Roy van der Meel